Moneycontrol PRO
HomeNewsOpinionUS price erosion triggers strategy rejig at Indian pharma

US price erosion triggers strategy rejig at Indian pharma

Drug suppliers rethink their investment strategy as continuous price erosion hurts profitability and returns from the US market

June 13, 2022 / 09:09 IST
Profit margins of the pharma companies contracted the most after the cement industry, as per an analysis of the March quarter earnings by Edelweiss research
Unlock This Article

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

Unlock exclusive discounts